Position
Chief Financial Officer
Company
Engrail Therapeutics
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Engrail Therapeutics announced the appointment of Paul Cayer as the chief financial officer and Saira Ramasastry to the company’s board of directors, with Ms. Ramasastry assuming the position of chair of the audit committee. The company also received a $10 million investment from Foresite Capital in an extension of the Series B financing.
Quick answer
Engrail Therapeutics Appoints Paul Cayer as Chief Financial Officer (August 8, 2024). Engrail Therapeutics is based in San Diego, California, United States.
- Who is the new Chief Financial Officer at Engrail Therapeutics?
- Engrail Therapeutics named Paul Cayer Chief Financial Officer, announced August 8, 2024.
- What did Engrail Therapeutics announce on August 8, 2024?
- Engrail Therapeutics announced the appointment of Paul Cayer as the chief financial officer and Saira Ramasastry to the company’s board of directors, with Ms. Ramasastry assuming the position of chair of the audit committee. The company also received a $10 million investment from Foresite Capital in an extension of the Series B financing.
- What does Engrail Therapeutics do?
- Engrail Therapeutics is a precision neuroscience company focused on developing transformational therapies to improve the lives of patients with neuropsychiatric and neurodevelopmental diseases.
- Where is Engrail Therapeutics based?
- Engrail Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Intra-Cellular Therapies (August 8, 2024), EXICURE, INC. (August 8, 2024), Fore Biotherapeutics (August 12, 2024) and Pathalys Pharma (August 13, 2024) also announced leadership changes within 45 days of Engrail Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Intra-Cellular Therapies Appoints Sanjeev Narula as Executive Vice President, Chief Financial Officer (August 8, 2024)
- Exicure, Inc. Appoints Anna Chukaeva as Senior Vice President, Head of Corporate Development and Bioinformatics (August 8, 2024)
- FORE Biotherapeutics Appoints Michael Byrnes as Chief Financial Officer (August 12, 2024)
- Pathalys Pharma Appoints Bastian Dehmel, M.D. as Chief Medical Officer (August 13, 2024)
- Thomas Mitro Named President & Chief Executive Officer of Signal12 Inc. (August 13, 2024)
- Pfizer Appoints Berta Rodriguez-Hervas as Chief AI and Analytics Officer (August 13, 2024)
Who to call at Engrail Therapeutics, and when
A new leader at Engrail Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Engrail Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Engrail Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Engrail Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Engrail Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Engrail Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.